![TANH](https://dbtnews.com/wp-content/uploads/2020/01/Image-69.png)
Wall Street Analyst Resumed Verona Pharma Plc ADR [VRNA]. What else is Wall St. saying
Verona Pharma Plc ADR [NASDAQ: VRNA] price plunged by -1.78 percent to reach at -$0.49. The one-year VRNA stock forecast points to a potential upside of 24.48. The average equity rating for VRNA stock is currently 1.00, trading closer to a bullish pattern in the